OSTEOPROTEGERIN, RANK, RANKL
Copyright policy )OSTEOPROTEGERIN, RANK, RANKL
Osteoprotegerin, RANK (Receptor Activator of Nuclear factor kappa B) and RANKL (Receptor Activator of Nuclear faktor kappa B ligand) became the aim of intensive research. RANK is considered as a hematopoietic surface receptor controlling osteoclastogenesis and calcium metabolism. RANKL may promote osteoresorption by induction of cathepsin K gene expression. The present paper summarizes the most significant data in osteoprotegerin, RANK and RANKL problems obtained.
- Palacký University, Olomouc Czech Republic
Membrane Glycoproteins, Receptor Activator of Nuclear Factor-kappa B, RANK Ligand, Osteoprotegerin, Osteoclasts, Receptors, Cytoplasmic and Nuclear, Receptors, Tumor Necrosis Factor, Animals, Humans, Carrier Proteins, Glycoproteins
Membrane Glycoproteins, Receptor Activator of Nuclear Factor-kappa B, RANK Ligand, Osteoprotegerin, Osteoclasts, Receptors, Cytoplasmic and Nuclear, Receptors, Tumor Necrosis Factor, Animals, Humans, Carrier Proteins, Glycoproteins
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).30 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!